Publicaciones en colaboración con investigadores/as de Centro Español de Investigación Farmacoepidemiológica (26)

2016

  1. Do case-only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 79-87

  2. Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: A cross-national descriptive study from the PROTECT-EU Project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 56-65

  3. Multi-centre, multi-database studies with common protocols: Lessons learnt from the IMI PROTECT project

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 156-165

  4. Prevalence of antibiotic use: A comparison across various European health care data sources

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 11-20

  5. Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case-control studies using two primary care databases in Europe

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 29-38

  6. The IMI PROTECT project: Purpose, organizational structure, and procedures

    Pharmacoepidemiology and Drug Safety, Vol. 25, pp. 5-10

2014

  1. Ascertainment of acute liver injury in two European primary care databases

    European Journal of Clinical Pharmacology, Vol. 70, Núm. 10, pp. 1227-1235

  2. Incidence rates and trends of hip/femur fractures in five European countries: Comparison using e-healthcare records databases

    Calcified Tissue International, Vol. 94, Núm. 6, pp. 580-589

2011

  1. Risk factors for intestinal ischaemia among patients registered in a UK primary care database: A nested case-control study

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 8, pp. 969-978

2008

  1. Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism

    Thrombosis Journal, Vol. 6

2006

  1. Non-steroidal anti-inflammatory drugs and risk of first hospital admission for heart failure in the general population

    Heart, Vol. 92, Núm. 11, pp. 1610-1615

2005

  1. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population

    American Journal of Kidney Diseases, Vol. 45, Núm. 3, pp. 531-539

  2. Respiratory medications and the risk of cardiac arrhythmias

    Epidemiology, Vol. 16, Núm. 3, pp. 360-366

2004

  1. Determinants of patient delay among tuberculosis cases in Spain

    European Journal of Public Health, Vol. 14, Núm. 2, pp. 151-155

2003

  1. Users of oral steroids are at a reduced risk of developing irritable bowel syndrome

    Pharmacoepidemiology and Drug Safety, Vol. 12, Núm. 7, pp. 583-588

2002

  1. Respiratory medications and risk of asthma death

    Thorax, Vol. 57, Núm. 8, pp. 683-686

  2. Risk of acute liver injury in patients with diabetes

    Pharmacotherapy, Vol. 22, Núm. 9 I, pp. 1091-1096

  3. Risk of clinical blood dyscrasia in a cohort of antibiotic users

    Pharmacotherapy, Vol. 22, Núm. 5, pp. 630-636

  4. Risk of irritable bowel syndrome among asthma patients

    Pharmacoepidemiology and Drug Safety, Vol. 11, Núm. 1, pp. 31-35

2001

  1. Are users of lipid-lowering drugs at increased risk of peripheral neuropathy?

    European Journal of Clinical Pharmacology, Vol. 56, Núm. 12, pp. 931-933